leisure time -WSS

leisure time

author：comprehensive 2025-08-24 09:38:35 - browse：83

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

Fresh off of the news that its drug Wegovy may not just help people lose weight, but could also lower cardiac risks, Novo Nordisk doubled down on its obesity drug pipeline Thursday, acquiring a small Canadian biotech with a new approach to weight loss.

Novo will spend up to $1 billion to buy Inversago Pharma, which is developing an oral obesity drug that targets the cannabinoid receptor CB1. It’s the second big obesity acquisition this year, following Eli Lilly’s move to purchase startup Versanis Bio.

Drugs like Wegovy are in a class called GLP-1 drugs, which mimic the effects of the glucagon-like peptide 1 hormone that help people feel full by targeting the hormone’s receptors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： FDA sets aggressive timeline for overhauling inspection procedures

knowledge

WSS

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

Immunocompromised patients offer clues on chronic Covid

A biotech analyst on neuroscience, placebo effect, not over

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

Emergent cuts jobs, executive role in business shake

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

focus

leisure time

entertainment

State Dept. review finds Biden bears some blame for Afghanistan failures

Printout prescription drug information shouldn’t go digital

Duchenne breakthrough therapy leaves behind pioneering families

Man killed during FBI raid in connection with threats against Biden, other officials

Heart attack and stroke risk calculators need revising

Head of FDA's diagnostics center, who led through Covid, retires

At least 13 dead in Texas as scorching temps continue

Dana Farber says 6 studies to be retracted and 31 corrected

Sports medicine is finally prioritizing gender equality

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

leisure time

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

TikTok, Instagram influencers need more rules for drug ads

To bolster infectious disease surveillance, genomics powerhouses team up

HPV vaccine, cervical cancer study delivers historic results

knowledge

explore

explore

knowledge